Lifileucel for previously treated unresectable or metastatic melanoma ID3863

Draft guidance

Draft guidance (downloadable version) (PDF 253 KB)

Public committee slides (PDF 758 KB)

Committee papers (PDF 8.84 MB)

Equality impact assessment (downloadable version) (PDF 133 KB)

Final scope (PDF 229 KB)

NICE's response to comments on the draft scope and provisional stakeholder list (PDF 230 KB)

Equality impact assessment (scoping) (PDF 128 KB)

Draft scope post referral (PDF 244 KB)

Draft scope post referral (PDF 244 KB)

Draft matrix post referral (PDF 190 KB)